Immunoactivating Peptide P4 Augments Alveolar Macrophage Phagocytosis in Two Diverse Human Populations

New treatment strategies are urgently needed to overcome early mortality in acute bacterial infections. Previous studies have shown that administration of a novel immunoactivating peptide (P4) alongside passive immunotherapy prevents the onset of septicemia and rescues mice from lethal invasive dise...

Descripción completa

Detalles Bibliográficos
Autores principales: Bangert, Mathieu, Wright, Adam K., Rylance, Jamie, Kelly, Matthew J., Wright, Angela D., Carlone, George M., Sampson, Jacquelyn S., Rajam, Gowrisankar, Ades, Edwin W., Kadioglu, Aras, Gordon, Stephen B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society for Microbiology 2013
Materias:
Experimental Therapeutics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3754341/
https://www.ncbi.nlm.nih.gov/pubmed/23817378
http://dx.doi.org/10.1128/AAC.00742-13

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3754341/
https://www.ncbi.nlm.nih.gov/pubmed/23817378
http://dx.doi.org/10.1128/AAC.00742-13

Ejemplares similares